An Innovative Advance to Increase the Use of the Vaccine Information Statement

Journal of Emergency Medicine

Volumn 33, Issue 1, 2007, Pages 81-89

  Edlich, Richard F ^a,b   Olson, Dana M ^c   Olson, Brianna M ^c   Greene, Jill Amanda ^c   Gubler, K Dean ^b   Winters, Kathryne L ^d   Poe, Maia J ^c   Britt, L D ^b   Long III, William B ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b LEGACY EMANUEL HOSPITAL   (United States)

^c Eastern Virginia Medical School ^*

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Vaccine Information Statement; Vaccine Injury Compensation Program

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INACTIVATED VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; VACCINE;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; EVALUATION; HUMAN; IMMUNIZATION; INFORMATION SYSTEM; MEDICAL EDUCATION; MEDICAL INFORMATION; PHYSICIAN; POLIOMYELITIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UNSPECIFIED SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); GUIDELINE ADHERENCE; HUMANS; IMMUNIZATION PROGRAMS; INFORMATION DISSEMINATION; MANDATORY PROGRAMS; PATIENT EDUCATION; UNITED STATES; VACCINATION; VACCINES;

EID: 34447314486     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2006.11.017     Document Type: Article

References (15)

1. Freed G.L., Katz S.L., and Clark S.J. Safety of vaccinations: Miss America, the media, and public health. JAMA 276 (1996) 1869-1872
2. Chen R.T., and Hibbs B. Vaccine safety: current and future challenges. Pediatr Ann 27 (1998) 445-455
3. Brink E.W., and Hinman A.R. The vaccine injury compensation act: the new law and you. Contemp Pediatr 6 (1989) 28-32 35-6,39,42
4. Chen R.T., Rastogi S.C., Mullen J.R., et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 12 (1994) 542-550
5. Varricchio F., Iskander J., Destefano F., et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 23 (2004) 287-294
6. U.S. Department of Health and Human Services, Health Resources and Services Administration. Vaccine Injury Compensation Program. Available at: http://www.hrsa.gov/osp/vicp.
7. National Immunization Program, Satellite Course on Vaccine Safety and Risk Communication (1998) February 26
8. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases, vaccine safety (chapter 15) (1997), Government Printing Office, Washington DC
9. Advisory Committee on Immunization Practice (ACIP). Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. MMWR Recomm Rep 46 (1997) 1-25
10. Davis T.C., Fredrickson D.D., Arnold C.L., et al. Childhood vaccine risk/benefit communication in private practice office settings: a national survey. Pediatrics 107 2 (2001) E17
11. Edlich R.F., Diallo A.O., Buchanan L., and Martin M.L. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States. J Long Term Eff Med Implants 13 (2003) 117-125
12. Ball L.K., Evans G., and Bostrom A. Risky business: challenges in Vaccine Risk Communication. Pediatrics 101 (1998) 453-458
13. Levinson W., Roter D.L., Mullooly J.P., Dull V.T., and Frankel R.M. Physician-patient communication. The relationship with malpractice claims among primary care physicians and surgeons. JAMA 277 (1997) 553-559
14. National Vaccine Advisory Committee. Report of the NVAC working group on philosophical exemptions (1998), National Vaccine Program Office, Centers for Disease Control and Prevention, Atlanta, GA
15. Edlich RF, Olson DM, Olson BM, et al. U.S. Department of Health and Human Services, Health Resources and Services Administration. National injury vaccine compensation. J Emerg Med; in press.